Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Hoyer

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
British Journal of Pharmacology|February 3, 2022
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathyRyan J Keenan, Heather Daykin, Jiahui Chu, et al.
Behavioural Brain Research|June 30, 2020
Circadian disruption impairs fear extinction and memory of conditioned safety in miceJacob W Clark, Daniel Hoyer, Sean W Cain, et al.
Neuropharmacology|April 15, 2005
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptorsDavide Cervia, Daniel Langenegger, Edi Schuepbach, et al.
Chimia|December 2, 2014
SOM230: a new therapeutic modality for Cushing's diseaseIan Lewis, Herbert A Schmid, Rainer Kneuer, et al.
Journal of Alzheimer'S Disease : JAD|December 28, 2020
Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510Ryan J Keenan, Sara Oberrauch, Romke Bron, et al.
Biological Psychiatry|December 25, 2007
The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learningStephanie Bissière, Nicolas Plachta, Daniel Hoyer, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonistsThomas Troxler, Daniel Hoyer, Daniel Langenegger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2003
Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptorsCaroline Nunn, Magnus Rueping, Daniel Langenegger, et al.
Brain Research|October 1, 2008
Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNAYann Senechal, Laetitia Prut, Peter H Kelly, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 8, 2019
The impact of backbone N-methylation on the structure-activity relationship of Leu<sub>10</sub> -teixobactinTony Velkov, James D Swarbrick, Maytham H Hussein, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
British Journal of Pharmacology|February 3, 2022
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathyRyan J Keenan, Heather Daykin, Jiahui Chu, et al.
Behavioural Brain Research|June 30, 2020
Circadian disruption impairs fear extinction and memory of conditioned safety in miceJacob W Clark, Daniel Hoyer, Sean W Cain, et al.
Neuropharmacology|April 15, 2005
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptorsDavide Cervia, Daniel Langenegger, Edi Schuepbach, et al.
Chimia|December 2, 2014
SOM230: a new therapeutic modality for Cushing's diseaseIan Lewis, Herbert A Schmid, Rainer Kneuer, et al.
Journal of Alzheimer'S Disease : JAD|December 28, 2020
Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510Ryan J Keenan, Sara Oberrauch, Romke Bron, et al.
Biological Psychiatry|December 25, 2007
The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learningStephanie Bissière, Nicolas Plachta, Daniel Hoyer, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 2007
Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonistsThomas Troxler, Daniel Hoyer, Daniel Langenegger, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 22, 2003
Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptorsCaroline Nunn, Magnus Rueping, Daniel Langenegger, et al.
Brain Research|October 1, 2008
Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNAYann Senechal, Laetitia Prut, Peter H Kelly, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 8, 2019
The impact of backbone N-methylation on the structure-activity relationship of Leu<sub>10</sub> -teixobactinTony Velkov, James D Swarbrick, Maytham H Hussein, et al.
Pageof 16